European Pharmaceutical Manufacturer editor Reece Armstrong sits down with World Courier president Sam Herbert to discuss the complexity of the pharma supply chain and the role the company has played on the industry’s world stage.
Rod Schregardus, supply chain technology specialist at Access Group, discusses the role of advanced planning and scheduling (APS) systems in pharmaceuticals manufacturing.
On the back of changing regulations for pharmaceutical security in the supply chain, we speak to Carlos Ruiz Martinez, pharma operations leader at Almirall to find out how companies are coping.
Sanjay Vyas, corporate vice president & Global SBU head of Clinical Trial Supplies & Logistics, PAREXEL International discusses the challenges in transporting certain medicines and how advancements in technology are making things easier.
Rod Schregardus, supply chain specialist at Access Group, looks at the growing importance of Advanced Planning and Scheduling (APS) systems in pharmaceuticals.
Stanley Chia, senior vice president at e-invoicing supplier, Tungsten Network, details the importance of secure supply chains in the age of the counterfeit drug.
In advance of new European measures to help reduce counterfeit medicines, Wayne Miller, healthcare director EMEA at Zebra Technologies, asks if the pharmaceutical supply chain is ready for true medicine traceability.
New technologies are changing the way pharmaceutical supply chains operate. Here, Marc Herlant, Arthur D. Little, discusses how predictive analytics offers pharmaceutical manufacturers new supply chain capabilities.
Chris Tozer, territory manager, UK, Ireland and Italy, Ivanti Supply Chain, looks at the complexities associated with the pharmaceutical supply chain and why legacy technology might be hindering efficiency.
